Inovio Pharmaceuticals
INO
INO
106 hedge funds and large institutions have $133M invested in Inovio Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 33 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less funds holding
Funds holding: 125 → 106 (-19)
62% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 21
Holders
106
Holding in Top 10
–
Calls
$1.01M
Puts
$716K
Top Buyers
| 1 | +$35.1M | |
| 2 | +$2.58M | |
| 3 | +$1.5M | |
| 4 |
TCM
Tanaka Capital Management
New York
|
+$642K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$458K |
Top Sellers
| 1 | -$2.07M | |
| 2 | -$1.21M | |
| 3 | -$1.06M | |
| 4 |
Citigroup
New York
|
-$872K |
| 5 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
-$861K |